Americans are more concerned about access to and the cost of prescription drugs than they are about the dynamics of health insurance networks and transparency in medical care pricing, a survey from the Kaiser Family Foundation reported.

Specialty drug costs might be the No. 1 issue for employers right now.

Because new payment models require effective and seamless care coordination among providers, new methods of delivering care have also been experiments in the living laboratory. Two in particular have become especially prominent.